Minnetonka-based Uroplasty Inc. said Friday that it has gained Medicare coverage for a urinary incontinence device in several mid-Atlantic states.

Novitas Solutions, a Medicare contractor, informed the Centers for Medicare and Medicaid Services on April 23 that it has retired non-coverage provisions concerning Posterior Tibial Nerve Stimulation (PTNS) effective for services incurred on or after April 9.

"Physicians treating Medicare beneficiaries in states served by Novitas may start submitting claims for PTNS treatments immediately," said David Kaysen, CEO of Uroplasty.

Novitas Solutions is the Medicare administrative contractor for Delaware, Maryland, New Jersey, Pennsylvania and the District of Columbia and provides medical and drug benefits to about 4.6 million Medicare beneficiaries.

Uroplasty's Urgent PC Neuromodulation System delivers PTNS treatments.